Search Within

Julie T Feldstein

Formats
  1. Journal Article (154)
  2. Meeting Abstract (138)
  3. Book Section (4)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (157)
  2. Hematologic Malignancies, Division of (139)
  3. Center for Hematologic Malignancies (133)
  4. Department of Pathology and Laboratory Medicine (91)
  5. Lymphoma (75)
  6. GSK Faculty (60)

More Groups

People
  1. Andrew Zelenetz (56)
  2. Daniel Filippa (47)
  3. Raymond Comenzo (36)
  4. Cyrus Hedvat (33)
  5. Craig Moskowitz (32)
  6. Raju Chaganti (32)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (1)
  6. 2018 (3)

More Years

Publications
  1. Blood (82)
  2. Modern Pathology (29)
  3. Laboratory Investigation (24)
  4. Nature (12)
  5. British Journal of Haematology (11)
  6. Applied Immunohistochemistry & Molecular Morphology (10)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Nature Publishing Group (49)
  3. Nature Research (29)
  4. Lippincott Williams & Wilkins (15)
  5. Cell Press (13)
  6. American Association for Cancer Research (12)

More Publishers

Results (298)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of EGFR expression in colorectal carcinomas, adenomas, and normal mucosa: A comparison between two commonly used antibodies
    Meeting Abstract

    Bhargava, R.; Chen, B.; Klimstra, D. S.; Hedvat, C.; Tang, L.; Gerald, W.; Teruya-Feldstein, J.; Shia, J.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
    Journal Article

    Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • A CK2-dependent mechanism for degradation of the PML tumor suppressor
    Journal Article

    Scaglioni, P. P.; Yung, T. M.; Cai, L. F.; Erdjument-Bromage, H.; Kaufman, A. J.; Singh, B.; Teruya-Feldstein, J.; Tempst, P.; Pandolfi, P. P.
    Cell (2006)

    Fulltext@MSK | Save
  • The combination of the proteasome inhibitor bortezomib and the Bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
    Journal Article

    O'Connor, O. A.; Smith, E. A.; Toner, L. E.; Teruya-Feldstein, J.; Frankel, S.; Rolfe, M.; Wei, X.; Liu, S.; Marcucci, G.; Chan, K. K.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer
    Journal Article

    Montanaro, L.; Brigotti, M.; Clohessy, J.; Barbieri, S.; Ceccarelli, C.; Santini, D.; Taffurelli, M.; Calienni, M.; Teruya-Feldstein, J.; Trerè€, D.; more...
    Journal of Pathology (2006)

    Fulltext@MSK | Save
  • Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Teruya-Feldstein, J.; Hamlin, P.; Yahalom, J.; Horwitz, S.; Nimer, S. D.; Moskowitz, C. H.
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: A possible surrogate marker of response?
    Journal Article

    Gerecitano, J.; Goy, A.; Wright, J.; Macgregor-Cortelli, B.; Neylon, E.; Gonen, M.; Esseltine, D.; Boral, A.; Schenkein, D.; Busam, K.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: Patients can have both monoclonal gammopathies and hereditary amyloid proteins
    Journal Article

    Comenzo, R. L.; Zhou, P.; Fleisher, M.; Clark, B.; Teruya-Feldstein, J.
    Blood (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save